Béla Denes, M.D., F.A.C.S.

Dr. Béla Denes is a board certified urologist trained at Washington University in St. Louis with more than 25 years of clinical practice in the diagnosis and treatment of men with prostate cancer. He joined Genomic Health in January 2013, to serve as the medical lead for the launch of the Oncotype DX prostate cancer test. In his current role, Dr. Denes leads physician education efforts and the development of the company’s prostate cancer test studies to demonstrate the value that the Oncotype DX prostate cancer test brings to patients and physicians in addressing overtreatment of low-risk prostate cancer. Prior to joining Genomic Health, Dr. Denes spent 10 years in development and medical affairs at Lilly, Pfizer, and Abbott.

PHEN,Inc. © 2018 All rights reserved